203 related articles for article (PubMed ID: 28083929)
1. The risk predictive values of UK-PBC and GLOBE scoring system in Chinese patients with primary biliary cholangitis: the additional effect of anti-gp210.
Yang F; Yang Y; Wang Q; Wang Z; Miao Q; Xiao X; Wei Y; Bian Z; Sheng L; Chen X; Qiu D; Fang J; Tang R; Gershwin ME; Ma X
Aliment Pharmacol Ther; 2017 Mar; 45(5):733-743. PubMed ID: 28083929
[TBL] [Abstract][Full Text] [Related]
2. Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis.
Efe C; Taşçilar K; Henriksson I; Lytvyak E; Alalkim F; Trivedi H; Eren F; Eliasson J; Beretta-Piccoli BT; Fischer J; Calişkan AR; Chayanupatkul M; Coppo C; Ytting H; Purnak T; Muratori L; Werner M; Muratori P; Rorsman F; Önnerhag K; Günşar F; Nilsson E; Heurgué-Berlot A; Güzelbulut F; Demir N; Gönen C; Semela D; Aladağ M; Kiyici M; Schiano TD; Montano-Loza AJ; Berg T; Ozaslan E; Yoshida EM; Bonder A; Marschall HU; Wahlin S
Am J Gastroenterol; 2019 Jul; 114(7):1101-1108. PubMed ID: 31241547
[TBL] [Abstract][Full Text] [Related]
3. Clinical performance of AMA-M2, anti-gp210 and anti-sp100 antibody levels in primary biliary cholangitis: When detected by multiplex bead-based flow fluorescent immunoassay.
Wang Z; Li Y; Ren L; Li Y; Xu T; Li W; Gao W; Sun G; Liu M
Immun Inflamm Dis; 2024 Jan; 12(1):e1161. PubMed ID: 38270327
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Biochemical Response Models for Primary Biliary Cholangitis and the Additional Role of the Neutrophil-to-Lymphocyte Ratio.
Yoo JJ; Cho EJ; Lee B; Kim SG; Kim YS; Lee YB; Lee JH; Yu SJ; Kim YJ; Yoon JH
Gut Liver; 2018 Nov; 12(6):714-721. PubMed ID: 30400732
[TBL] [Abstract][Full Text] [Related]
5. Anti-gp210-positive primary biliary cholangitis: The dilemma of clinical treatment and emerging mechanisms.
Wang X; Yang Z; Ran Y; Li L; Wang B; Zhou L
Ann Hepatol; 2023; 28(5):101121. PubMed ID: 37302574
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to gp210 and understanding risk in patients with primary biliary cholangitis.
Haldar D; Janmohamed A; Plant T; Davidson M; Norman H; Russell E; Serevina O; Chung K; Qamar K; Gunson B; Hansen B; Richter A; Trivedi PJ; Hirschfield GM
Liver Int; 2021 Mar; 41(3):535-544. PubMed ID: 33022821
[TBL] [Abstract][Full Text] [Related]
7. Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis.
Huang C; Han W; Wang C; Liu Y; Chen Y; Duan Z
Dis Markers; 2019; 2019():9121207. PubMed ID: 31737133
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of antibodies to gp210 among patients with primary biliary cholangitis in Northeast China.
Chen Q; Zhong R; Dong K; Wang Y; Kui Y; Ma B; Wen X; Jin Q
Dig Liver Dis; 2022 Aug; 54(8):1094-1100. PubMed ID: 34789400
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).
Nguyen HH; Shaheen AA; Baeza N; Lytvyak E; Urbanski SJ; Mason AL; Norman GL; Fritzler MJ; Swain MG
PLoS One; 2018; 13(3):e0193960. PubMed ID: 29554146
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune Markers in Primary Biliary Cholangitis.
Shah SK; Bowlus CL
Clin Liver Dis; 2024 Feb; 28(1):93-101. PubMed ID: 37945165
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy.
Lammers WJ; Hirschfield GM; Corpechot C; Nevens F; Lindor KD; Janssen HL; Floreani A; Ponsioen CY; Mayo MJ; Invernizzi P; Battezzati PM; Parés A; Burroughs AK; Mason AL; Kowdley KV; Kumagi T; Harms MH; Trivedi PJ; Poupon R; Cheung A; Lleo A; Caballeria L; Hansen BE; van Buuren HR;
Gastroenterology; 2015 Dec; 149(7):1804-1812.e4. PubMed ID: 26261009
[TBL] [Abstract][Full Text] [Related]
12. Implication of increased serum stromal cell-derived factor-1 for primary biliary cholangitis.
Yang Z; Liang Y; Lin F; Zhang Z; Luo W; Zhang Y; Zhong R
Int Immunopharmacol; 2018 Mar; 56():285-290. PubMed ID: 29414663
[TBL] [Abstract][Full Text] [Related]
13. Presence of anti-gp210 or anti-sp100 antibodies in AMA-positive patients may help support a diagnosis of primary biliary cholangitis.
Jaskowski TD; Nandakumar V; Novis CL; Palmer M; Tebo AE
Clin Chim Acta; 2023 Feb; 540():117219. PubMed ID: 36610465
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis.
Itoh S; Ichida T; Yoshida T; Hayakawa A; Uchida M; Tashiro-Itoh T; Matsuda Y; Ishihara K; Asakura H
J Gastroenterol Hepatol; 1998 Mar; 13(3):257-65. PubMed ID: 9570238
[TBL] [Abstract][Full Text] [Related]
15. [Study of clinical characteristics in patients with gp210 antibody-positive primary biliary cholangitis].
Huang CY; Liu YM; Liu H; Xu B; Yan HP; Zhang HP; Liao HY; Zhang XD; Zhao J; Li WJ; Duan ZP
Zhonghua Gan Zang Bing Za Zhi; 2022 Apr; 30(4):419-425. PubMed ID: 35545568
[No Abstract] [Full Text] [Related]
16. Role of autoantibodies in the clinical management of primary biliary cholangitis.
Rigopoulou EI; Bogdanos DP
World J Gastroenterol; 2023 Mar; 29(12):1795-1810. PubMed ID: 37032725
[TBL] [Abstract][Full Text] [Related]
17. Increased sensitivity of gp210 autoantibody detection using a newly designed gp210 antigen.
Xu J; Zhang H; Wang C; Jiang P; Han C; Dai Y; Qiu F; Gong Y; Jiang Y; Xu P; Zhang M; Zhang L; Shi X; Chen S; Tian Y; Seldin MF; Gershwin ME; Liu X; Li L
J Immunol Methods; 2022 Feb; 501():113211. PubMed ID: 34971632
[TBL] [Abstract][Full Text] [Related]
18. Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland.
Terziroli Beretta-Piccoli B; Stirnimann G; Cerny A; Semela D; Hessler R; Helbling B; Stickel F; Kalid-de Bakker C; Bihl F; Giostra E; Filipowicz Sinnreich M; Oneta C; Baserga A; Invernizzi P; Carbone M; Mertens J
Clin Rev Allergy Immunol; 2018 Apr; 54(2):295-306. PubMed ID: 29181702
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of autoimmune liver disease related autoantibodies in Chinese patients with primary biliary cirrhosis.
Hu C; Deng C; Song G; Zhang W; Zhang S; Li X; Li P; Zhang F; Li Y
Dig Dis Sci; 2011 Nov; 56(11):3357-63. PubMed ID: 21660486
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of primary biliary cirrhosis and disease-associated autoantibodies in Japanese patients with systemic sclerosis.
Imura-Kumada S; Hasegawa M; Matsushita T; Hamaguchi Y; Encabo S; Shums Z; Norman GL; Takehara K; Fujimoto M
Mod Rheumatol; 2012 Nov; 22(6):892-8. PubMed ID: 22327744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
